StockWatch
·

Knack Packaging Ltd Q1 FY27 Results

KNACKQ1 FY27 Results
Filing
Result:Good· Market: UpBroad basedMargin expansionCost led

Outlook: Optimistic · Guidance: None

MetricValueChange
Revenue262.46 Cr
Total Income264.77 Cr
Expenditure219.48 Cr
PBT45.29 Cr
Net Profit30.53 Cr
OPM21.66%
NPM11.53%
EPS3.05
View full financials

Revenue +41% and PAT +48% YoY were broad-based with genuine margin expansion (17.3% vs 15.0%), but the margin gain was partly a mechanical effect of a large finished-goods inventory build cushioning COGS, a driver flagged to reverse, so it falls short of a clean standout.

KNACK PACKAGING · Q1 FY27 · THE VERDICT

40% Growth Delivered, Zero Forward Guidance: The Knack Paradox

Knack posted a spectacular Q1—40.5% revenue growth, 48% PAT jump, and 170 bps of margin expansion—but management refuses to forecast ahead, saying only it will 'maintain' this quarter's level. The interim reliance on rented capacity and Oct 2027 plant commissioning explain the caution.

13 Aug 2026 · 6 min read

Knack Packaging delivered a blockbuster Q1 FY27: revenue ₹264.77 Cr (+40.5% YoY), PAT ₹30.53 Cr (+48% YoY), and EBITDA margin 22.35% (up 170 bps). The reported profit is clean—no MTM gains, no exceptional items. The organic earnings story is real. Yet on the call, management offered zero forward guidance beyond 'expect to maintain' this quarter's sales level through October 2027 interim capacity. That gap between the spectacular print and the flat-to-modest guidance is the tension that defines this quarter.

Revenue YoY

+40.5%

₹264.77 Cr; volume +20.9%

PAT YoY

+48%

₹30.53 Cr; NPM 11.5% vs 11.0%

EBITDA margin

+170 bps

22.35% vs 20.65% Q1 FY26

FY27 guidance

None

Management: 'expect to maintain' Q1 level

The organic earnings story—and why no guidance?

Knack's Q1 profit has no hidden subsidies. The 48% PAT jump came from three levers: (1) volume growth of 20.9% (10,940 tons vs 9,047 tons), (2) mix shift toward higher-margin pinch-bottom bags (23% of volumes, up from 19–20%), and (3) cost discipline via conversion-cost contracts with 45–50% of the customer base (e.g., Cargill on 'material price + fixed conversion' model) and solar-driven electricity savings (1.1% YoY). EBITDA per kg jumped from ₹45 FY26 to ₹54 Q1 FY27—a 20% lift. All of this is documented and corroborated by the delivered result.

But management refused to quantify FY27–28 revenue or margin targets. When analyst Nihal Shah asked for EBITDA per kg guidance, CFO Alpesh Patel deflected: 'Our specialty is making bags. Profit will come automatically.' The silence on forward guidance is deliberate, not accidental. Knack is managing expectations because growth sustainability hinges entirely on two rented manufacturing plants (5,040 tons/year capacity added Q4 FY26–Q1 FY27) that run until October 2027, when a new company-owned facility (26.7k tons, ₹380 Cr CapEx) is slated to commission. That 15-month window is the execution test. If the new plant delays, rented capacity is neither cost-effective nor scalable beyond this interim phase. Flat guidance = 'we'll hold here until we know the new asset is live.'

Management's claims vs. what holds up

40.5% YoY revenue growth driven by volume and capacity utilization

Revenue ₹264.77 Cr vs ₹187.17 Cr Q1 FY26; volume 10,940 tons vs 9,047 tons (20.9% growth). Numbers exact match.

Supported

EBITDA margin 22.35%, up 170 bps YoY

EBITDA ₹59.17 Cr (22.35% margin) vs ₹38.64 Cr (20.65% margin) Q1 FY26. Exact.

Supported

PAT margin improved to 11.53%

Delivered ₹30.5 Cr, NPM 11.5%; call shows ₹30.53 Cr, 11.53%. Essentially matched.

Supported

No genuine peer; market leader in pinch-bottom niche

Technopack report: 10% Knack market share. No listed competitor. Polytex (USA) 50% higher cost (₹0.70–0.75 vs ₹0.35–0.40/bag). Thailand/Cambodia higher labor/electricity.

Supported

Cargill business grew from ₹6 Cr (2020) to ₹140 Cr (annualized run-rate)

Q1 sales ~₹30–31 Cr (12% of ₹264.77 Cr total); annualized ≈ ₹120–124 Cr. ₹140 Cr appears to conflate prior-year annualization or blend with projected SKU expansion.

Slightly overstated

What changed on this call

Strategic moves and operational updates
  • Pinch-bottom mix ramping: Two ₹20 Cr specialty machines installed Q4 FY26; Q1 volumes at 23% pinch-bottom (up from 19–20% prior). EBITDA per kg ₹54 (vs ₹45 FY26, ₹33 FY24). Customers switching from standard PLWPP for 6-sided branding (vs 4-side stitched).

  • Interim capacity leased: Two rented facilities (5,040 tons/year combined) added Q4 FY26 + Q1 to manage growth bottleneck. Asset-light model maintains 91–92% utilization. Winds down October 2027 when new plant goes live.

  • Solar farm operational: 11 MW facility (Khedbrahma) saving 1.1% electricity YoY (₹1.6 Cr forex gain also booked Q1).

  • Global footprint expanded: 74 countries (up from 71 FY26), 6 continents. Cargill (USA + 7 others) now 12% of sales, 600+ SKU, 2+1-year contract.

The bull-bear ledger

  • Market leader in niche with high stickiness: 90% customer retention, 2,000+ customers, 13,000+ SKU. Cargill stayed through 50% US tariffs (2019–20). Pinch-bottom differentiation (branding ROI) drives switching cost.

  • Strong organic profit growth: 48% PAT growth, 170 bps margin expansion, zero one-time items. Cost structure transparent (conversion-cost contracts, SAP forecasting, bulk buying, solar).

  • Clear execution track record: IPO (₹320 Cr capital) completed Aug 2026. Pinch-bottom machines on schedule. Rented capacity live and operating. New plant (₹380 Cr, 26.7k tons) construction on track for October 2027.

  • Customer concentration risk: Cargill = 12% of revenue (₹30–31 Cr/quarter, ₹120–124 Cr annualized). Loss would hit ~10% topline. Stickiness high (contract expires 2+1 years, <1% of their end-cost), but single-customer dependency is real.

  • Raw material volatility and margin defense dependency: Polypropylene tied to crude (volatile). 45–50% customers on conversion-cost model (margin protected); 45–50% small players face pressure if crude spikes. No guarantee of 100% pass-through on smaller SKU.

  • New plant execution risk: ₹380 Cr CapEx, October 2027 target. Rented interim capacity expires same month. If commissioning delays, growth stalls and margins compress (rented capacity 60–70 bps lower margin than owned assets). No contingency disclosed.

  • Interim capacity is cost headwind and growth ceiling: Rented plants 15–20% lower margin vs owned assets. 5,040 tons/year rented = 10% of new plant capacity. If new plant is delayed >6 months, rented cost becomes prohibitive or capacity exhausted.

  • Zero forward guidance despite 40% growth: Management's refusal to quantify FY27–28 targets leaves scope for disappointment if growth doesn't sustain. 'Maintain Q1 levels' = flat guidance, not acceleration. Premium multiple unjustified until new plant proves scalable.

  • Export exposure and forex volatility: 55% of revenue from exports (74 countries). Q1 forex gain ₹1.6 Cr, but currency can reverse. Cargill (12% sales, largest customer) has USD contract, but smaller export customers unhedged.

How the street is positioned

Knack's stock price action post-result tells its own story. Announced Sun Aug 09, stock opened to a +3.35% pop (day 1) from ₹208.34 pre-result close. By day 3, that had faded to –2.72% net, closing at ₹204.56 (as of Aug 13). The initial enthusiasm didn't hold—a subtle signal that the street recognizes the headline beat but is pricing in execution risk on the new plant and the absence of forward guidance.

Knack is now 7.86% below its all-time high of ₹222, having recovered +11.79% from its 52-week low of ₹182.98. RSI sits at 57.7 (neutral territory), and volume is normal. At ₹204.56, assuming FY27–28 earnings of ~₹120–130 Cr (extrapolating Q1 organic run-rate if maintained), the stock trades at roughly 9–10× trailing annualized earnings—not expensive, but not cheap for a company with zero forward guidance and interim capacity dependencies.

Institutional positioning is mixed. FII ownership 1.21% (minimal), DII 9.31%, promoters 70.59% (early IPO, locked-in). Recent bulk dealing (mid-July) shows trading activity—algorithmic shops (Mathisys, Yuga, QE Securities, Microcurves) cycling positions near ₹210–215, no insider-linked selling detected near the highs. The muted institutional interest and low FII touch suggest the street is waiting for October 2027 plant proof before upgrading conviction.

The debate

Risks ranked by holder concern

What could go wrong, and why it matters to you

New plant commissioning delay (beyond October 2027)

High

Rented interim capacity is not sustainable beyond October 2027; margins are 60–70 bps lower than owned assets. Delay by >6 months forces either (a) margin compression to maintain volume, or (b) volume contraction to preserve margin. Either stalls growth story and stock re-rating.

Customer concentration (Cargill 12% sales)

Medium–High

Loss or material contraction of Cargill (~₹120–124 Cr annualized) would hit 10% topline. While contract stickiness is proven (tariff test), any strategic shift by Cargill (e.g., in-sourcing, alternate supplier) is an uninsured tail risk.

Raw material price spike (crude → polypropylene) with delayed pass-through

Medium

45–50% customers on conversion-cost model (margin protected), but 45–50% small players absorb spikes. If crude rallies >20% YoY, smaller SKU margin erosion could offset the pinch-bottom gains. No guidance on margin floor.

Interim rented capacity exhaustion or cost escalation

Medium

Two rented facilities (5,040 tons/year) added for interim growth. If demand outpaces rented capacity OR landlord rent increases, Knack faces squeezed margins or growth ceiling until new plant is live.

Export forex reversal (55% of revenue exposed)

Low–Medium

Q1 forex gain ₹1.6 Cr (ITM gains on receivables). If INR strengthens, forex headwind could flip to –₹1–2 Cr range, pressuring PAT by 3–6%. Cargill (12% sales) is USD-hedged, but smaller export customers are not.

Capacity underutilization post-new plant

Low

If growth slows post-October 2027, new plant 70k-ton total capacity could drop to 60–70% utilization, compressing margins via fixed-cost leverage. Management is confident on ₹130 Cr order book, but no guarantee.

What to watch next

Three concrete things that will resolve the debate by Q4 FY27
  • 1 · New plant commissioning progress (October 2027 target)

    Q2 and Q3 updates should confirm construction on track, no cost overruns, crew hiring/training proceeding. Any delay signal should trigger valuation reset (–15–20% downside). October 2027 live commissioning with first capacity ramp would be upgrade catalyst.

  • 2 · Pinch-bottom mix expansion and EBITDA per kg trajectory

    Q2 / Q3 updates on pinch-bottom % of volume (target 25%) and EBITDA per kg run-rate (can it sustain ₹54 or exceed it?). If pinch-bottom stalls <25% or EBITDA per kg rolls back to ₹45–50, margin resilience narrative fractures.

  • 3 · Cargill onboarding into new markets and revenue acceleration

    Management claimed 8-country Cargill footprint and ₹140 Cr annualized run-rate. Q2 / Q3 must show sequential expansion in SKU count (>600) and country count (>8) to validate the 'global Cargill scaling' thesis. Flattening Cargill growth would signal mature-phase risk.

The number to track

Forget the headline PAT for now. Track EBITDA per kg—it's the fingerprint of Knack's true operational health. Q1 FY27 ₹54 per kg (vs ₹45 FY26, ₹33 FY24) is the key. If it holds or grows (₹55–58) through Q2–Q4 as pinch-bottom mix expands and solar/cost optimization compounds, management's 'profit will come automatically' thesis holds and the new plant should unlock a step-change. If it rolls back to ₹48–50, the margin expansion is temporary and driven by mix/one-time items (solar), not sustainable operational leverage. That single metric will tell you whether Knack's Q1 beat is the start of a new normal or a peak quarter before capacity constraints bite.

Knack posted a genuine strong quarter. The 40.5% revenue growth, 48% PAT growth, and 170 bps margin expansion are real—no accounting sleight of hand. But management's refusal to guide forward reveals the true story: this is a transition company. For 15 months (until October 2027), it will run on interim rented capacity and cost discipline. If the new plant delivers on schedule and margin integrity holds, the next leg is a step-change. If either slips, you're looking at a stalled growth story with concentration risk.

Verdict: Hold. Conviction score 7/10. Wait for October 2027 plant commissioning proof and Q4 FY27 sustained margins before upgrading to Buy. Fair entry point at current ₹204, breakeven on Q2 guidance (or lack thereof). If you own it, collect the steady earnings while the new asset is built. If you don't, wait for the next quarterly update on construction progress.

Informational and educational content only. Not investment advice.